# BioMime Vs. Xience Randomised Control Clinical Study

> **NCT02112981** · NA · UNKNOWN · sponsor: **Meril Life Sciences Pvt. Ltd.** · enrollment: 256 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Sirolimus Eluting Coronary Stent
- **DEVICE:** Everolimus-eluting Coronary stent

## Key facts

- **NCT ID:** NCT02112981
- **Lead sponsor:** Meril Life Sciences Pvt. Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-11-05
- **Primary completion:** 2017-09-06
- **Final completion:** 2019-12-01
- **Target enrollment:** 256 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02112981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02112981, "BioMime Vs. Xience Randomised Control Clinical Study". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02112981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*